Showing results (331-340 of 10,340) with videos related to

Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|December 4, 2020
Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosusXianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, et al.
Annals of the Rheumatic Diseases|October 29, 2020
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programmeStanley B Cohen, Ronald F van Vollenhoven, Kevin L Winthrop, et al.
Annals of the Rheumatic Diseases|December 3, 2020
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Annals of the Rheumatic Diseases|December 3, 2020
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivoSilvia Menegatti, Vincent Guillemot, Eleonora Latis, et al.
Annals of the Rheumatic Diseases|December 21, 2017
Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from SwedenKarin Bengtsson, Helena Forsblad-d'Elia, Elisabeth Lie, et al.
Annals of the Rheumatic Diseases|March 9, 2018
Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence studyStanley B Cohen, Alberto Alonso-Ruiz, Piotr A Klimiuk, et al.
Annals of the Rheumatic Diseases|March 15, 2018
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre studyGuillaume Moulis, Grégory Pugnet, Nathalie Costedoat-Chalumeau, et al.
Annals of the Rheumatic Diseases|September 1, 1988
Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosusM A Blaschek, M Boehme, J Jouquan, et al.
Annals of the Rheumatic Diseases|September 1, 1988
Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literatureM G Ridley, C S Wolfe, J A Mathews
Annals of the Rheumatic Diseases|December 18, 2013
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
Pageof 1,034